• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORPORATION ADVANCED PERFUSION SYSTEM 1; CONSOLE, HEART-LUNG MACHINE, CARDIOPULMONARY BYPASS-ADVANCED PERFUSION SYSTEM 1

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORPORATION ADVANCED PERFUSION SYSTEM 1; CONSOLE, HEART-LUNG MACHINE, CARDIOPULMONARY BYPASS-ADVANCED PERFUSION SYSTEM 1 Back to Search Results
Model Number 801074
Device Problems Out-Of-Box Failure (2311); Failure to Calibrate (2440)
Patient Problem No Patient Involvement (2645)
Event Date 02/16/2018
Event Type  malfunction  
Manufacturer Narrative
No patient involvement.Failure to calibrate, 2311 - out-of-box failure.O2 sensor.Per srt, during testing the central control monitor (ccm) read 76.4 while the o2 analyzer read 79.8.Specifications to pass testing are +/- 3% of each other.
 
Event Description
The service repair technician (srt) reported that during routine testing of the device at the service center, the oxygen (o2) sensor failed "o2 sensor calibration" testing at 80%.There was no patient involvement.
 
Manufacturer Narrative
The reported complaint was confirmed.Per the manufacturer's supplier, the out of range readings were confirmed.The cause was determined to be a crack or fissure in the cathode.If additional information becomes available on this complaint that would alter the facts and/or conclusion, a supplemental report will be filed accordingly.
 
Manufacturer Narrative
The reported complaint was confirmed.During laboratory analysis, the product surveillance technician (pst) installed the oxygen (o2) sensor into a lab use (epgs).He connected the epgs to a system 1 simulator and central control monitor (ccm), attached o2 and air at 50 psi and entered a perfusion screen on the ccm.After the 15-minute warm-up period, calibration of the epgs was initiated and passed.The measurement of the direct current (d/c) output voltage from the o2 sensor at 5 l/min and 100% o2 was 1.60 volts, within the specification of.55-2.758 volts.After calibration, set flow at 5 l/min and o2 at 80%.The ccm displayed 80.3% while an external analyzer displayed 76.2%.If additional information becomes available on this complaint that would alter the facts and/or conclusion, a supplemental report will be filed accordingly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVANCED PERFUSION SYSTEM 1
Type of Device
CONSOLE, HEART-LUNG MACHINE, CARDIOPULMONARY BYPASS-ADVANCED PERFUSION SYSTEM 1
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
6200 jackson road
ann arbor MI 48103
MDR Report Key7332195
MDR Text Key102215868
Report Number1828100-2018-00119
Device Sequence Number1
Product Code DTQ
Combination Product (y/n)N
PMA/PMN Number
K022947
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup,Followup
Report Date 08/30/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date04/18/2018
Device Model Number801074
Device Catalogue Number801074
Was Device Available for Evaluation? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 02/16/2018
Initial Date FDA Received03/12/2018
Supplement Dates Manufacturer Received03/29/2018
08/10/2018
Supplement Dates FDA Received04/23/2018
08/30/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-